Anson Funds Management’s GSK GSK Stock Holding History

Anson Funds Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-68,000	Closed	-$2.46M	–	183
2023 Q3	$2.46M	Hold	68,000	–	–	0.5%	48
2023 Q2	$2.42M	Hold	68,000	–	–	0.4%	46
2023 Q1	$2.42M	Hold	68,000	–	–	0.4%	57
2022 Q4	$2.39M	Buy	68,000 +40,000	+143%	+$1.33M	0.39%	51
2022 Q3	$824K	Hold	28,000	–	–	0.1%	166
2022 Q2	$1.52M	Sell	28,000 -16,000	-36%	-$883K	0.14%	116
2022 Q1	$2.4M	Buy	+44,000	New	+$2.39M	0.19%	94
2021 Q4	–	Sell	-48,000	Closed	-$2.29M	–	360
2021 Q3	$2.29M	Hold	48,000	–	–	0.22%	108
2021 Q2	$2.39M	Buy	+48,000	New	+$2.31M	0.23%	110
2020 Q1	–	Sell	-11,040	Closed	-$648K	–	83
2019 Q4	$648K	Buy	+11,040	New	+$614K	0.75%	33

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Anson Funds Management's GSK Position: Q4 2023 in Review

Anson Funds Management sold out of GSK (GSK) in Q4 2023, closing a stake of 68,000 shares — an estimated $2.46M sold.

Anson Funds Management first reported a position in GSK in Q4 2019 and held it in 10 quarters. The position peaked at $2.46M in Q3 2023. 895 funds tracked by Wall St. Rank hold GSK as of Q4 2023.

Anson Funds Management reported no remaining GSK position as of Q4 2023 after selling out during the quarter.
Anson Funds Management sold 68,000 GSK shares in Q4 2023, an estimated $2.46M.
Anson Funds Management first reported a position in GSK in Q4 2019 and held it in 10 quarters.
Anson Funds Management's GSK position peaked at $2.46M in Q3 2023.
895 funds tracked by Wall St. Rank held GSK as of Q4 2023.

Based on Anson Funds Management's 13F filing for Q4 2023, filed 14 Feb 2024.